Vitamin B3 (Niacin)
water-soluble
Key Takeaways
- Precursor to NAD+ and NADP+, coenzymes involved in 400+ enzymatic reactions including energy metabolism, DNA repair, and cell signaling
- FDA daily value is 16 mg NE (niacin equivalents); body can also synthesize niacin from tryptophan (60 mg tryptophan = 1 mg NE)
- Deficiency causes pellagra (dermatitis, diarrhea, dementia, death if untreated), now rare in developed countries due to food fortification
- Available as nicotinic acid (causes vasodilatory flushing) and nicotinamide/niacinamide (no flushing); both serve as NAD+ precursors
- Emerging research explores niacin's potential neuroprotective roles in Alzheimer's, Parkinson's, and multiple sclerosis through Hcar2 receptor pathways
Evidence Spectrum
14 studies reviewed →Pellagra prevention and treatment
Niacin deficiency causes pellagra, characterized by photosensitive dermatitis, gastrointestinal symptoms, and neuropsychiatric ailments. Pellagra currently develops primarily in people who chronically abuse alcohol or are treated with immunosuppressive and anti-tuberculosis drugs. The ESPEN guideline identifies niacin as a critical micronutrient requiring monitoring in at-risk populations during nutritional support.
Cellular energy metabolism and brain function
As a precursor to NAD+ and NADP+, niacin is essential for energy production, DNA/RNA synthesis/repair, and the synthesis of numerous neurochemicals and signaling molecules. Adequate levels of all B vitamins are essential for optimal neurological functioning, and a significant proportion of developed-country populations suffer from deficiencies or insufficiencies in one or more B vitamins.
Neuroprotective potential
Recent evidence positions niacin as a promising therapeutic candidate for several neurological disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease, glioblastoma, and ALS. Proposed mechanisms include Hcar2 receptor-mediated immune regulation, phagocytosis of myelin debris and amyloid beta, and cholesterol efflux. Clinical validation is still needed.
Skin health and dermatological applications
Topical nicotinamide demonstrates anti-inflammatory, antimicrobial, photo-protective, sebostatic, and lightening effects. Clinical trials show it attenuates skin aging and hyperpigmentation. Six of eight studies using topical nicotinamide led to significant reduction in acne. Vitamin B3 derivatives improved rosacea symptoms in 76-80% of patients in clinical studies. The substance works by regulating cellular redox status and inhibiting NF-kB-mediated transcription via PARP-1 inhibition.
Immune regulation
B group vitamins serve as cofactors for hundreds of enzymes carrying out essential immune functions. Evidence of B vitamins' role in immune cell regulation has accumulated in recent years, though the complexity of their essential functions complicates an unequivocal assessment of their effects in inflammation and cancers.
Role in the Body
Vitamin B3 (niacin) encompasses nicotinic acid and nicotinamide, both precursors to NAD+ and NADP+. These coenzymes participate in over 400 enzymatic reactions central to energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation), DNA synthesis and repair, and genomic/non-genomic methylation. NAD+ also serves as a substrate for PARPs (DNA repair) and sirtuins (stress response and longevity signaling). Beyond metabolism, niacin engages the hydroxycarboxylic acid receptor 2 (Hcar2), mediating immune regulation, phagocytosis, and cholesterol efflux. The body can synthesize niacin from tryptophan at approximately 60:1 ratio. B vitamins including niacin perform closely inter-related roles in cellular functioning and are particularly important for brain function, including neurochemical synthesis and signaling.
- Precursor to NAD+ and NADP+ coenzymes
- Cellular energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation)
- DNA synthesis, repair, and methylation
- Cell signaling and stress response via sirtuins and PARPs
- Immune regulation and phagocytosis via Hcar2 receptor
- Neurochemical synthesis and brain function support
Supplement Forms
Nicotinic acid (niacin)
RecommendedBioavailability: 0.7%
Causes vasodilatory flushing above 35 mg via prostaglandin-mediated mechanism. Prescription doses (1-3 g) historically used for dyslipidemia. Sustained-release forms carry higher hepatotoxicity risk.
Nicotinamide (niacinamide)
RecommendedBioavailability: 0.7%
No flushing. Most common OTC supplement form. Well-tolerated topically for dermatological applications. Restores cellular NAD+ pool and mitochondrial energetics.
Nicotinamide riboside (NR)
Bioavailability: 0.5%
NAD+ precursor marketed for anti-aging. Limited clinical evidence compared to nicotinic acid and nicotinamide. More expensive.
Food Sources
Poultry (chicken, turkey)
Fish (tuna, salmon)
Beef and pork
Fortified cereals and bread
Peanuts and peanut butter
Mushrooms
Green peas
Avocado (1.3 mg per half fruit)
Deficiency
Prevalence: Pellagra is rare in developed countries due to food fortification. Remains a concern in corn-dependent diets without nixtamalization, chronic alcoholism, and during immunosuppressive or anti-tuberculosis therapy. Vegan diets are associated with lower niacin intake compared to other dietary patterns. Increased ultra-processed food consumption correlates with decreased niacin intake.
Symptoms:
- Dermatitis (photosensitive, bilateral, symmetrical skin lesions)
- Diarrhea and gastrointestinal symptoms
- Dementia and neuropsychiatric symptoms
- Death if untreated (the 4 Ds of pellagra)
- Cutaneous manifestations affecting hair, skin, and nails
Risk Factors:
- Corn/maize-dependent diets without nixtamalization
- Chronic alcoholism
- Immunosuppressive drug therapy
- Anti-tuberculosis drugs (isoniazid)
- Carcinoid syndrome (tryptophan diverted to serotonin)
- Hartnup disease
- High ultra-processed food diets
- Restrictive vegan diets without planning
Safety & Interactions
Possible Side Effects:
- • Vasodilatory flushing with nicotinic acid above 35 mg (not with nicotinamide)
- • Hepatotoxicity at pharmacological doses (1-3 g/day), especially sustained-release formulations
- • Gastrointestinal upset at high doses
- • Nicotinamide is well tolerated topically and orally at standard doses
Drug Interactions:
- • Statins: increased myopathy risk with high-dose niacin
- • Isoniazid: depletes niacin, may precipitate pellagra
- • Alcohol: increases niacin requirements and depletion risk
- • Other B vitamins: inter-related metabolism; complex supplementation may be more rational than isolated supplementation
Contraindications:
- • Active liver disease
- • Active peptic ulcer disease
- • Severe hypotension
Frequently Asked Questions
What is the difference between niacin and niacinamide?
Both are forms of vitamin B3 that serve as precursors to NAD+. Niacin (nicotinic acid) causes vasodilatory flushing at doses above 35 mg and was historically used for dyslipidemia. Niacinamide (nicotinamide) does not cause flushing and is the most common OTC supplement form, also used topically for skin conditions.
What causes niacin flushing and is it harmful?
Nicotinic acid triggers prostaglandin-mediated vasodilation, causing skin redness, warmth, and tingling. While uncomfortable, it is not harmful. The effect is dose-dependent and diminishes with continued use. Niacinamide does not cause flushing.
Can I get enough vitamin B3 from food alone?
Yes, for most people. Poultry, fish, beef, fortified cereals, peanuts, and mushrooms are rich sources. The FDA daily value of 16 mg NE is achievable through a varied diet. However, vegan diets and high ultra-processed food consumption are associated with lower niacin intake.
What are the symptoms of niacin deficiency?
Severe deficiency causes pellagra, characterized by the 4 Ds: dermatitis (photosensitive, symmetrical skin lesions), diarrhea, dementia, and death if untreated. Today, pellagra primarily occurs in chronic alcoholism and with certain medications like isoniazid.
Is niacin being studied for neurological conditions?
Yes. Emerging research explores niacin as a potential therapeutic for Alzheimer's, Parkinson's, multiple sclerosis, and other neurological disorders. The proposed mechanisms involve the Hcar2 receptor, which mediates immune responses and clearance of pathological proteins. Clinical trials are still needed to confirm these findings.
Research Sources
14 peer-reviewed studies analyzed from PubMed. 0 directly cited in this review.